Royal Philips Electronics has released its earnings report for the first quarter of 2011. Overall, Philips group sales were EUR 5.3 ($7.5 USD) billion, with EBITA of EUR 437 ($622 USD) million, or 8 percent of sales.

CEA-Leti, a French research and technology organization, has started a new project designed to develop a nanocarrier-based approach to improve the treatment of inflammatory bowel disease (IBD).

Myocardial perfusion SPECT with prone and half-time imaging, which nearly halves acquisition time, is feasible and associated with good image quality in most studies, according to research published in the May issue of Nuclear Medicine Communications.

Aushon BioSystems has launched its next generation SignaturePLUS imaging and analysis system for multiplex protein biomarker analysis across preclinical, clinical and diagnostics applications in all therapeutic areas.

Eisais U.S. subsidiary Morphotek has acquired certain assets relating to a proprietary tumor targeting platform from TransMolecular.

Caliper Life Sciences has launched XenoLight RediJect COX-2 Probe (Fluorocoxibs), a fluorescent imaging agent for preclinical research that specifically detects the cyclooxygenase-2 (COX-2) biomarker noninvasively in live animal models as well as in ex vivo tissue analysis applications.

The Medical Research Council in London, Imperial College London, Kings College London and University College London have become equal shareholders in a newly created joint venture with GlaxoSmithKlinesClinical Imaging Center.

Nearly one year after initial findings indicated that intraoperative single-dose radiation is as effective as whole-breast radiation therapy in limiting recurrence of breast cancer in selected patients, physicians at Northwestern Memorial Hospital in Chicago are offering the condensed treatment to a select group of patients.